BR9714625A -
Composition and use of it.
- Google Patents
Composition and use of it.
Info
Publication number
BR9714625A
BR9714625ABR9714625ABR9714625ABR9714625ABR 9714625 ABR9714625 ABR 9714625ABR 9714625 ABR9714625 ABR 9714625ABR 9714625 ABR9714625 ABR 9714625ABR 9714625 ABR9714625 ABR 9714625A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ravi Shrivastava, Lab RemileafiledCriticalRavi Shrivastava
Priority to BR9714625ApriorityCriticalpatent/BR9714625A/en
Priority claimed from PCT/FR1997/000370external-prioritypatent/WO1998039018A1/en
Publication of BR9714625ApublicationCriticalpatent/BR9714625A/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
''COMPOSIçãO E UTILIZAçãO DA MESMA''. Composição de um salicóide e de um partenóide, ou de plantas ou de extratos de plantas contendo estes dois princípios ativos, sua utilização em um processo de tratamento terapêutico do corpo humano ou animal, ou para a preparação de um medicamento destinado, principalmente, ao tratamento da enxaqueca, e composições, particularmente farmacêuticas, que os incluem.'' COMPOSITION AND USE OF THE SAME ''. Composition of a salicoid and a parenoid, or of plants or plant extracts containing these two active principles, their use in a therapeutic treatment process of the human or animal body, or for the preparation of a medicine intended mainly for the treatment migraine, and compositions, particularly pharmaceuticals, that include them.
BR9714625A1997-03-031997-03-03
Composition and use of it.
BR9714625A
(en)
PREPARATIONS FOR THE APPLICATION OF ANTI-INFLAMMATORY, ESPECIALLY, ANTI-SEPTIC AGENTS AND / OR WOUND HEALING PROMOTION AGENTS, IN THE SUPERIOR AND / OR HEARING RESPIRATORY TRACT
Pharmaceutical composition, processes to prevent or treat a disease, to prevent or treat alzheimer's disease in a patient, to evaluate the effectiveness of an alzheimer's treatment process in a patient, to monitor alzheimer's disease or susceptibility to it in a patient, use of a * peptide or an antibody thereof, composition, and set of diagnoses for monitoring the treatment of alzheimer's disease
Use of a recombinant adenovirus of animal origin Recombinant adenovirus of animal origin and pharmaceutical composition comprising one or more adenoviruses
Compound, process for preparing it, pharmaceutical composition, process for preparing it, use of a compound, and, processes for effecting immunosuppression and for treating or reducing the risk of reversibly obstructive airway disease in a patient
Pharmaceutical or veterinary process and composition for prophylactic or therapeutic inhibition of a toxic material or substance in a human or non-human animal patient, and use of an anionic or cationic dendrimer
Use of organophosphate compounds for the production of pharmaceutical preparations for the therapeutic and prophylactic treatment of infections or as a fungicide, bactericide or herbicide in plants